Complement C1 esterase inhibitor and Insulin glargine, recombinant Subcutaneous
Determining the interaction of Complement C1 esterase inhibitor and Insulin glargine, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: C1 esterase inhibitor (human)
Brand name: Berinert, Cinryze, Haegarda, Ruconest
Synonyms: C1 Inhibitor (Human)
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Complement C1 esterase inhibitor-Insulin glulisine
- Complement C1 esterase inhibitor-Insulin Glulisine (Cartridges and Pens)
- Complement C1 esterase inhibitor-Insulin Glulisine (Vials)
- Complement C1 esterase inhibitor-Insulin glulisine Subcutaneous
- Complement C1 esterase inhibitor-Insulin human inhaled Inhalation
- Complement C1 esterase inhibitor-Insulin human regular Injection
- Insulin glargine, recombinant Subcutaneous-Complera
- Insulin glargine, recombinant Subcutaneous-Complete Allergy
- Insulin glargine, recombinant Subcutaneous-Complete-RF Prenatal
- Insulin glargine, recombinant Subcutaneous-Complex A Tretinoin Cream
- Insulin glargine, recombinant Subcutaneous-Compliments Bismuth - Regular Strength
- Insulin glargine, recombinant Subcutaneous-Compound W